PREOPERATIVE HYPOFRACTIONED RADIOTHERAPY IN LOCALIZED EXTREMITY/TRUNK WALL SOFT TISSUE SARCOMAS EARLY STUDY RESULTS Hanna Kosela ; Milena Kolodziejczyk; Tadeusz Morysinski; Wirginiusz Dziewirski; Marcin Zdzienicki; Piotr Rutkowski Department of Soft Tissue/Bone Sarcoma and Melanoma, Department of Radiotherapy Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Warsaw, Poland
34
Embed
PREOPERATIVE HYPOFRACTIONED RADIOTHERAPY IN LOCALIZED EXTREMITY/TRUNK WALL SOFT TISSUE SARCOMAS EARLY STUDY RESULTS Hanna Kosela; Milena Kolodziejczyk;
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
PREOPERATIVE HYPOFRACTIONED RADIOTHERAPY IN LOCALIZED
EXTREMITY/TRUNK WALLSOFT TISSUE SARCOMAS
EARLY STUDY RESULTS
Hanna Kosela; Milena Kolodziejczyk; Tadeusz Morysinski; Wirginiusz Dziewirski; Marcin Zdzienicki; Piotr Rutkowski
Department of Soft Tissue/Bone Sarcoma and Melanoma, Department of Radiotherapy
Maria Sklodowska-Curie Memorial Cancer Center and Institute of OncologyWarsaw, Poland
Background
Primary treatment of majority of localized soft tissue sarcoma is surgical resection of the tumor with adequate margins combined with radiotherapy
Using radiotherapy in the local setting increases local control of the disease (with suggested survival benefit for patients with high grade tumors*)
*Koshy M, et al. . Improved survival with radiation therapy in high-grade soft tissue sarcomas of the extremities: a SEER analysis. Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):203-9
Background – preoperative radiotherapy vs postoperative setting
No differences in local recurrence rate, regional and distant failure rates*;*O'Sullivan B, et al. . Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial.2002 Jun 29;359(9325):2235-41.
Benefits Drawbacks
• Lower doses and smaller treatment field size;
• Possible improvement in tumor resectability;
• Smaller incidence in long term radiation- related complications;
Increased risk of wound complications;
Background
Can we shorten the overall treatment time by using hypofractionated radiotherapy and immediate surgery in STS as in rectal carcinoma?
Incidence of late complicatons and local recurrences compared to those observed after conventionally fractionated preoperative radiotherapy.
Overall survival;
Patients and methodsIn the years 2006-2010, 262 patients
received 5x5 Gy according to uniform internal preoperative protocol and underwent tumor resection within a consecutive week.
In our analysis we included only
patients with diagnosis of localized, resectable soft tissue sarcoma of the extremities or trunk wall (confirmed pathologically): primary or recurrent; deep seated and/or intermediate/high grade
Patients and methods
• 225 patients• 122 (54%) women, 103 (46%) men• Median age 54 years (range 18-82) • Median follow up 34 months (range 1-80)• Bioethical committee approval
Patients and methods
140 patients (62.2%)- primary tumors• 75 patients (33%) – clinical local recurrence after
previous surgery in another center• 10 patients (4.4%)- after non-radical surgery in
another center, but without clinical recurrence (scar)
56 (24.9%) patients received preoperative chemotherapy
75% of these patients had high grade tumors (G3)
Patients and methods
67.50%
14.70%
17.80%
Tumor localization
Lower limb
Trunk wall
Upper limb
Patients and methods
Synovial sarcoma
Patients and methods
* 16 patients had also postoperative radiotherapy
Tumor size Median size 9cm (range 0,5-41cm)45%>10cm
Tumor grade 29- G1
54-G2
136- G3 (60%)
6- unknown
Final resection margin 176- R0 (78%)
41- R1*
2-R2
Results
• 51 (22.6%) patients were dead at the time of analysis
• 93 (41.3%) recurrences of the disease• 46 - local recurrence (20% local recurrence =
80% local control rate) - in 10 patients after local recurrence amputation was performed
• 78 (34.7%)- distant metastases• 31 (13.8%) patients had local and distant
recurrence of the disease
Overall survival (median - not reached)
0 10 20 30 40 50 60
T ime (months)
0,0
0,1
0,2
0,3
0,4
0,5
0,6
0,7
0,8
0,9
1,0
Survival probability
65%
~70%
L o ca l re cu rre n ce -fre e su rvi va l (m e d ia n - n o t re a ch e d )